<DOC>
	<DOCNO>NCT01714401</DOCNO>
	<brief_summary>Patients ICU 's often require bronchodialtatory treatment due bronchospazm cause condition like : ARDS , COPD asthma . The Î²2 adreneregic drug one commonly use purpose . However know may cause tachycardia may substantial proarrhythmic effect . The investigator ' aim estimate influence nebulized bronchodilatatory drug select electrophysiological parameter , whose change generally recognize potentially increase risk ventricular supraventricular arrhythmia . Two drug compare - salbutamol give two dos ipratropium bromide</brief_summary>
	<brief_title>Nebulized Bronchodilatators Cardiac Repolarization</brief_title>
	<detailed_description />
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>necessity b2 adrenergic m2 mimetics administration patient past medical history ventricular arrhythmia ( ventricular tachycardia , ventricular fibril , Torsade de pointes ) patient persistent atrial fibrillation patient abnormal plasma sodium , potassium , magnesium , ionized calcium concentration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>